These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5134459)

  • 1. Serum cortisol in chronic schizophrenia. Changes in the diurnal rhythm and psychiatric mental status on withdrawal of drugs.
    Franzĕn G
    Psychiatr Clin (Basel); 1971; 4(4):237-46. PubMed ID: 5134459
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum cortisol in chronic schizophrenia. Changes in the response to intravenously administered insulin and ACTH on withdrawal of drugs.
    Franzén G
    Acta Psychiatr Scand; 1971; 47(2):150-62. PubMed ID: 4336844
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum cortisol in chronic schizophrenia. A study of the adrenocortical response to intravenously administered insulin and ACTH.
    Franzén G
    Acta Psychiatr Scand; 1971; 47(1):82-91. PubMed ID: 4337085
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of Tybamate in chronic schizophrenia. (Minor tranquilizers as adjunct therapy in psychosis).
    Serafetinides EA; Clark ML
    Dis Nerv Syst; 1971 Aug; 32(8):567-71. PubMed ID: 5094163
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of phenothiazines on anxiety and cognition in schizophrenia.
    Meadow A; Donlon PT; Blacker KH
    Dis Nerv Syst; 1975 Apr; 36(4):203-8. PubMed ID: 234827
    [No Abstract]   [Full Text] [Related]  

  • 6. Doxepin as adjuvant medication in the treatment of chronic schizophrenic patients: a comparative study.
    Sterlin C; Augustin E; Ban TA; Jarrold L
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):50-2. PubMed ID: 4992566
    [No Abstract]   [Full Text] [Related]  

  • 7. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
    Ban TA; Ananth JV; Lehmann HE
    Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sudden cessation of psychotropic drugs].
    Avrutskii GIa; Gurovich IIa; Prokhorova IS; Tirkel'taub IuA; Romanov IuD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(6):923-30. PubMed ID: 4156142
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical effects of various schedules of medication.
    Chien CP; DiMascio A
    Behav Neuropsychiatry; 1971; 3(1):5-9. PubMed ID: 5566336
    [No Abstract]   [Full Text] [Related]  

  • 10. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 11. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum cortisol in chronic schizophrenia. A study of the siurnal rhythm in relation to psychiatric mental status.
    Franzén G
    J Psychosom Res; 1971 Sep; 15(3):367-73. PubMed ID: 5564447
    [No Abstract]   [Full Text] [Related]  

  • 14. Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach.
    Baro F; Van Lommel R; Dom R; De Mesmaecker L
    Acta Psychiatr Belg; 1972 Mar; 72(2):199-214. PubMed ID: 5056015
    [No Abstract]   [Full Text] [Related]  

  • 15. The assessment and clinical implications of haloperidol acute-dose, steady-state, and withdrawal pharmacokinetics.
    Khot V; DeVane CL; Korpi ER; Venable D; Bigelow LB; Wyatt RJ; Kirch DG
    J Clin Psychopharmacol; 1993 Apr; 13(2):120-7. PubMed ID: 8463444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 17. Some effects of mesoridazine (TPS-23) on chronic psychiatric patients.
    Douglas KW; Hindley JP; Kerin MT
    Dis Nerv Syst; 1967 Feb; 28(2):113-7. PubMed ID: 6021590
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of dosage ranges of carphenazine and trifluoperazine in elderly chronic schizophrenics.
    Bora G
    Dis Nerv Syst; 1968 Oct; 29(10):695-7. PubMed ID: 4887393
    [No Abstract]   [Full Text] [Related]  

  • 19. Coadministration of fluvoxamine increases serum concentrations of haloperidol.
    Daniel DG; Randolph C; Jaskiw G; Handel S; Williams T; Abi-Dargham A; Shoaf S; Egan M; Elkashef A; Liboff S
    J Clin Psychopharmacol; 1994 Oct; 14(5):340-3. PubMed ID: 7806690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of Navane concentrate and tablets].
    Radmayr E
    Wien Z Nervenheilkd Grenzgeb; 1968; 26(4):340-60. PubMed ID: 4241209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.